What Happened?
Hayward, CA-based Eikon Therapeutics Promoted Russ Berman as Chief Technology Officer
About the Company
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases. Eikon`s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells.
About the Person
Russ Berman is Chief Technology Officer at Eikon Therapeutics. Previously, Russ held various senior IT leadership roles in the industry.
Info Source
News
Short Profile